Clinical Chemistry Analyzers Market worth $16.5 billion by 2028
The report "Clinical Chemistry Analyzers Market by Product (Fully-automated and PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) & Region - Global Forecast to 2028", size is projected to reach USD 16.5 billion by 2028 from USD 13.0 billion in 2023, at a 4.9% CAGR.
Browse 122 market data Tables and 39 Figures spread through 194 Pages and in-depth TOC on "Clinical Chemistry Analyzers Market by Product (Fully-automated and PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) & Region - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/clinical-chemistry-analyzer-market-144027310.html
The clinical chemistry analyzers market is witnessing growth due to several factors, including the rise in the elderly population and the higher occurrence of chronic and lifestyle diseases. The increasing adoption of point-of-care testing devices and the growing demand for laboratory automation are also contributing to this growth. Additionally, emerging economies like China and Japan are offering profitable prospects for companies involved in the clinical chemistry analyzers market.
Reagents segment accounted for the largest share of the clinical chemistry analyzers market, by product segment, in 2022
The clinical chemistry analyzers market is categorized into reagents, analyzers, and other products based on the product type. In 2022, the reagents segment held the largest market share in the clinical chemistry analyzers market. The primary driver for the growth of this segment is the consistent and high demand for reagents, which surpasses the demand for analyzers.
Lipid profile tests segment to register the highest growth rate during the forecast period
Segmented by test type, the clinical chemistry analyzers market includes basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests. In 2022, the lipid profile tests segment exhibited the highest growth rate in the market. This growth can be attributed to the rapid increase in obesity rates and the rising prevalence of diseases associated with obesity.
The hospitals and clinics segment accounted for the largest share of the clinical chemistry analyzers market, by end user segment, in 2022
The clinical chemistry analyzers market is divided into hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and other end users based on end-users. In 2022, hospitals and clinics held the largest market share in the clinical chemistry analyzers market. The growth of this segment is primarily driven by factors such as the rising global incidence of diseases and disorders, the growing adoption of analyzers in healthcare settings, and continuous technological advancements.
North America is the largest regional market for clinical chemistry analyzers market
The clinical chemistry analyzers market is categorized into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the largest market share in the clinical chemistry analyzers market. The dominant position of this region can be attributed to various factors, including the growing geriatric population, rising incidence of chronic and lifestyle diseases, favorable government initiatives, increased healthcare expenditure, improved healthcare infrastructure, and the presence of technologically advanced instruments.
The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), HORIBA Ltd. (Japan), Sysmex Corporation (Japan), HITACHI (Japan), EKF Diagnostics (UK), Ortho Clinical Diagnostics (US), ELITech Group (France), Mindray Medical International Ltd. (China), BIOBASE Group (China), SFRI Medical Diagnostics (France), Trivitron Healthcare Pvt. Ltd. (India), Randox Laboratories Ltd. (UK), Medica Corporation (US), Meril Life Sciences Pvt. Ltd. (India), Erba Mannheim (UK), Genrui Biotech Inc. (China), DIRUI Industrial Co. Ltd. (China), Teco Diagnostics (US), Balio Diagnostics (France), Snibe Co. Ltd. (China), and AMS Alliance (Italy).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Clinical Chemistry Analyzers Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
